Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Fifth Pacific Stop TB Meeting Nadi, Fiji Islands May 4-7, 2010 Meeting objectives 1. Review progress against the regional and international targets for TB control 2. Provide an overview of interventions designed to improve TB control and aid progression towards the achievement of revised regional targets 3. Provide clinical and programmatic training for doctors, nurses and laboratory technicians involved in TB control in the Pacific Day 1 – Tuesday, 4 May 2010 Time From To 0830 0850 0900 0930 0940 1000 1030 1100 1120 0920 0940 1000 1030 1100 1120 1150 1150 1200 1210 1220 1230 1200 1210 1220 1230 1330 1330 1350 1410 1430 1450 1510 1530 1545 1615 1830 1350 1410 1430 1450 1510 1530 1545 1615 1625 1900 Session Registration INTRODUCTION AND BACKGROUND Opening remarks and prayer Aims and objectives International TB situation Regional TB situation Morning Tea and Photo TB treatment guidelines (4th edition) Draft Strategic Plan for TB Control in the Western Pacific Region: 2011-2015 GDF and TB DRUG MANAGEMENT Global Drug Facility updates Report on 2009 TB drug management workshop Country experience with GDF: Solomon Islands Country experience with GDF: Federated States of Micronesia Lunch DRUG RESISTANT TB MDR-TB Infection control Green Light Committee/ Regional access to second line TB drugs Country update: MDR-TB in FSM Country experience: MDR-TB in RMI Country experience: Service delivery model to prevent drug resistant TB Afternoon Tea MDR-TB Framework for the Pacific Island countries and territories Introduction to parallel sessions on Wednesday 5 May WELCOME COCKTAIL Presenter Representatives from CDC, SPC and WHO Dr Axel Wiegandt (SPC) Dr Daniel Sagebiel (WHO) Dr Janet O’Connor (SPC) Dr Linh Nguyen (WHO) Dr Daniel Sagebiel (WHO) Dr Linh Nguyen (WHO) Dr Iobi Batio (Fiji School of Medicine) Mr Noel Itogo (Solomon Islands MHMS) Dr Mayleen Ekiek (FSM MoH) Dr Sundari Mase (CDC) Dr Richard Brostrom (CNMI MoH) Dr Daniel Sagebiel (WHO) Dr Mayleen Ekiek (FSM MoH) Ms Risa Bukbuk (RMI MoH) Dr Takeieta Kienene (Kiribati MHMS) Dr Axel Wiegandt (SPC) Ms Kerri Viney (SPC) Day 2 – Wednesday, 5 May 2010 Time From To 0800 1030 Session CONCURRENT TRAINING SESSIONS: Laboratory, physician and nursing sessions Training programs to be provided in the separate sessions Presenter Physician training co-ordinated by: Drs Richard Stapledon, Sundari Mase and Anastasios Konstantinos Laboratory training co-ordinated by: Mr David Dawson, Ms Vasiti Uluiviti and Ms Sala Elbourne Nursing training co-ordinated by: Ms Kerrie Shaw and Ms Pam Banner 1030 1100 1230 1100 1230 1330 1530 1545 1545 1700 Morning Tea CONCURRENT TRAINING SESSIONS: Laboratory, physician and nursing sessions Lunch CONCURRENT TRAINING SESSIONS: Laboratory, physician and nursing sessions Afternoon Tea CONCURRENT TRAINING SESSIONS: Laboratory, physician and nursing sessions Day 3 – Thursday, 6 May 2010 Time From To 0750 0800 Session 0800 0820 0820 0840 DAY ONE SUMMARY TB SCREENING Regional contact tracing guideline Screening in high risk populations 0840 0900 0900 0920 How to implement contact tracing in the Pacific Treatment of latent TB infection 0920 1000 1030 1000 1030 1045 1045 1105 1125 1140 1200 1215 1230 1105 1125 1140 1200 1215 1230 1330 1330 1345 1400 1345 1400 1420 1420 1450 1450 1500 1500 1530 1530 1545 1545 1615 1615 1640 HIGH RISK GROUPS TB and diabetes TB and HIV Morning Tea LABORATORY New diagnostic tools PaTLab co-ordination/ operation External quality assessment: the role of National TB Programmes Drug resistance surveillance Role of TB culture in the Pacific: the northern Pacific experience Role of TB culture in the Pacific: the southern Pacific experience Lunch SURVEILLANCE WHO TB surveillance SPC TB surveillance Epi Anywhere MONITORING AND EVALUATION Conducting monitoring and evaluation in Pacific National TB Programmes STRATEGIC HEALTH COMMUNICATION Strategic health communication for National TB Programmes UPDATE FROM CDC Update from CDC on TB control activities in the Northern Pacific Afternoon Tea OPERATIONAL RESEARCH TB/ diabetes study in Kiribati TB genotyping study in Kiribati Presenter Rapporteur Ms Kerri Viney (SPC) Dr Vicki Krause (Dept of Health and Families: NT Government) Ms Kerrie Shaw (Australian Respiratory Council) Dr Vicki Krause (Dept of Health and Families: NT Government) Dr Richard Brostrom (CNMI MoH) Dr Mitzi Nisbet (Auckland City Hospital) Dr Matthew Bankowski (Diagnostic Laboratory Services) Mr David Dawson (PaTLab) Ms Robyn Carter (Queensland Health) Mr David Dawson (PaTLab) Ms Vasiti Uluiviti (PIHOA) Ms Sala Elbourne (SPC) Dr Daniel Sagebiel (WHO) Ms Kerri Viney (SPC) Dr Joe Kabel (Looking Glass Analytics) Dr Richard Stapledon (SA Health) Mr Jovesa Saladoka (SPC) Mr Andy Heetderks (CDC) Dr Sundari Mase (CDC) Ms Eman Aleksic (Burnet Institute) Day 4 – Friday, 7 May 2010 Time From To 0750 0800 0800 1030 1030 1100 1100 1300 1300 1400 1400 1520 1520 1530 DAY THREE SUMMARY POSTER PRESENTATION Morning Tea RECORDING AND REPORTING WORKSHOP Lunch CONCLUSIONS AND RECOMMENDATIONS CLOSING 1530 Afternoon Tea 1545 Session List of Abbreviations: CDC CNMI FSM MHMS MoH NT PaTLab PIHOA RMI SA SPC WHO Centers for Disease Control and Prevention Commonwealth of the Northern Mariana Islands Federated States of Micronesia Ministry of Health and Medical Services Ministry of Health Northern Territory Pacific TB Laboratory network Pacific Island Health Officers Association Republic of Marshall Islands South Australia Secretariat of the Pacific Community World Health Organization Presenter Rapporteur National TB Programme staff/ CDC/ SPC/ WHO Dr Axel Wiegandt and Dr Linh Nguyen (SPC/ WHO) Dr Daniel Sagebiel and Dr Janet O’Connor (WHO/SPC) Dr Daniel Sagebiel and Dr Janet O’Connor and Mr Andy Heetderks (WHO/SPC/CDC)